Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Summary

The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with perennial allergic rhinitis (PAR).

Timeline

Start

2006-02-07

Primary completion

2006-07-01

Completion

2006-07-04

Outcome

Met primary endpoint

registry analysis (superiority or other test); Placebo vs Fluticasone Furoate; p <0.001; Mean Difference (Final Values) -1.256 (95% CI -1.73 to -0.78) NCT00289198 ↗

Drugs

Indications